Skip to main content

Table 3 Hepatitis B virus and hepatitis C virus serological status

From: Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors

  Total (n = 388) [n (%)]
HBV exposed 33 (8.5)
Chronic HBV infection a 1 (0.3)
Past HBV infection 32 (8.3)
  Isolated anti-HBc b 8 (2.0)
  Anti-HBc (+) and 24 (6.2)
  anti-HBs (+) c  
HBV vaccine d 56 (14.4)
HBV negative e 299 (77.0)
HCV positive 5 (1.3)
HCV negative 383 (98.7)
  1. HBV: hepatitis B virus; HCV: hepatitis C virus
  2. a HBsAg (+), anti-HBc (+), anti-HBs (−) b HBsAg (−), anti-HBc (+), anti-HBs (−) c HBsAg (−), anti-HBc (+), anti-HBs (+) d HBsAg (−), anti-HBc (−), anti-HBs (+) [anti-HBs ≥ 10 IU/mL] e HBsAg (−), anti-HBc (−), anti-HBs (−)